Page last updated: 2024-09-04

cox 189 and Vertigo

cox 189 has been researched along with Vertigo in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Derbot, J; Jung, T; Krammer, G; Kreiss, A; Litschig, S; Mysler, E; Tate, GA; Thurston, H; Willburger, RE	1

Trials

1 trial(s) available for cox 189 and Vertigo

Article	Year
Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout. Rheumatology (Oxford, England), 2007, Volume: 46, Issue:7 Topics: Abdominal Pain; Acute Disease; Administration, Oral; Adult; Aged; Analysis of Variance; Argentina; Diclofenac; Double-Blind Method; Drug Administration Schedule; Female; Germany; Gout; Headache; Humans; Indomethacin; Joints; Logistic Models; Male; Middle Aged; Pain Measurement; Treatment Outcome; Vertigo	2007

Article

Year

Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout.

Rheumatology (Oxford, England), 2007, Volume: 46, Issue:7

Topics: Abdominal Pain; Acute Disease; Administration, Oral; Adult; Aged; Analysis of Variance; Argentina; Diclofenac; Double-Blind Method; Drug Administration Schedule; Female; Germany; Gout; Headache; Humans; Indomethacin; Joints; Logistic Models; Male; Middle Aged; Pain Measurement; Treatment Outcome; Vertigo

2007